Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (191-200 of 372) with videos related to

Pageof 38
Sort By:
Antiviral Therapy|July 7, 2009
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotypeAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.
The American Journal of Gastroenterology|August 28, 2004
Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapyRoberta Soffredini, Maria Grazia Rumi, Maria Luisa Parravicini, et al.
Journal of Hepatology|July 23, 2003
Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissectionMassimo Iavarone, Jean-Baptiste Trabut, Oona Delpuech, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 18, 2018
Electrostatic-Driven Gelation of Colloidal NanocrystalsTaisiia Berestok, Pablo Guardia, Maria Ibáñez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutantsLucio Caccamo, Raffaella Romeo, Giorgio Rossi, et al.
Haematologica|October 5, 2006
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis CMaria Elisa Mancuso, Maria Grazia Rumi, Elena Santagostino, et al.
Antiviral Therapy|September 7, 2013
Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritisStella De Nicola, Alessio Aghemo, Maria Rosaria Campise, et al.
Antiviral Therapy|October 9, 2009
The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirinMauro Viganò, Alessio Aghemo, Massimo Iavarone, et al.
Antiviral Therapy|February 22, 2007
Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infectionAlessio Aghemo, Maria Grazia Rumi, Roberta Soffredini, et al.
Journal of Hepatology|March 27, 2013
The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological responseRoberta D'Ambrosio, Alessio Aghemo, Mirella Fraquelli, et al.
Pageof 38

Showing results (191-200 of 372) with videos related to

Sort By:
Pageof 38
Antiviral Therapy|July 7, 2009
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotypeAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.
The American Journal of Gastroenterology|August 28, 2004
Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapyRoberta Soffredini, Maria Grazia Rumi, Maria Luisa Parravicini, et al.
Journal of Hepatology|July 23, 2003
Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissectionMassimo Iavarone, Jean-Baptiste Trabut, Oona Delpuech, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 18, 2018
Electrostatic-Driven Gelation of Colloidal NanocrystalsTaisiia Berestok, Pablo Guardia, Maria Ibáñez, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutantsLucio Caccamo, Raffaella Romeo, Giorgio Rossi, et al.
Haematologica|October 5, 2006
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis CMaria Elisa Mancuso, Maria Grazia Rumi, Elena Santagostino, et al.
Antiviral Therapy|September 7, 2013
Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritisStella De Nicola, Alessio Aghemo, Maria Rosaria Campise, et al.
Antiviral Therapy|October 9, 2009
The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirinMauro Viganò, Alessio Aghemo, Massimo Iavarone, et al.
Antiviral Therapy|February 22, 2007
Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infectionAlessio Aghemo, Maria Grazia Rumi, Roberta Soffredini, et al.
Journal of Hepatology|March 27, 2013
The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological responseRoberta D'Ambrosio, Alessio Aghemo, Mirella Fraquelli, et al.
Pageof 38